Margarita Glazova

Dr. Margarita Glazova

Institute of Evolutionary Physiology and Biochemistry, Saint Petersburg, Sankt-Peterburg, Russia
orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 1999 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
WHWolfgang Hauser
Wolfgang Hauser
KKKlaus-Peter Knobeloch
Klaus-Peter Knobeloch
MEMartin Eigenthaler
Martin Eigenthaler
Stepan GambaryanStepan Gambaryan
Stepan Gambaryan
VKVeit Krenn
Veit Krenn
MZMichael Zimmer
Michael Zimmer
Vasodilator-stimulated phosphoprotein (VASP), a substrate of cAMP- and cGMP-dependent protein kinases, is associated with focal adhesions, cell–cell contacts, microfilaments, and highly dynamic membrane regions. VASP, which is expressed in most cell types and in particularly high levels in human platelets, binds to profilin, zyxin, vinculin, F-actin, and theListeria monocytogenessurface protein ActA. VASP is a member of the enabled (Ena)/VASP protein family and is thought to be involved in actin filament formation and integrin αIIbβ3inhibition in human platelets. To gain further insight into thein vivofunction of this protein, VASP-deficient mice were generated by homologous recombination. VASP−/− mice demonstrated hyperplasia of megakaryocytes in bone marrow and spleen but exhibited no other macroscopic or microscopic abnormalities. Activation of platelets with thrombin induced a more than 2-fold higher surface expression of P-selectin and fibrinogen binding in VASP-deficient platelets in comparison to wild type. These data support the concept that VASP is a negative modulator of platelet and integrin αIIbβ3activation. Although the limited phenotypic differences between wild-type and VASP−/− mice suggested functional compensation of VASP by members of the Ena/VASP family, alterations in the expression levels of mammalian enabled (Mena) and Ena-VASP-like (Evl) protein were not detected. VASP-deficient mice may provide an interesting model system for diseases in which enhanced platelet activation plays a major role.

1 October 2000 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
MBMick Burkhardt
Mick Burkhardt
MGMargarita Glazova
Margarita Glazova
Stepan GambaryanStepan Gambaryan
Stepan Gambaryan
TVTobias Vollkommer
Tobias Vollkommer
EBElke Butt
Elke Butt
APAlois Palmetshofer
Alois Palmetshofer
Many signal transduction pathways are mediated by the second messengers cGMP and cAMP, cGMP- and cAMP-dependent protein kinases (cGK and PKA), phosphodiesterases, and ion channels. To distinguish among the different cGMP effectors, inhibitors of cGK and PKA have been developed including the K-252 compound KT5823 and the isoquinolinesulfonamide H89. KT5823, an in vitro inhibitor of cGK, has also been used in numerous studies with intact cells to implicate or rule out the involvement of this protein kinase in a given cellular response. However, the efficacy and specificity of KT5823 as cGK inhibitor in intact cells or tissues have never been demonstrated. Here, we analyzed the effects of both KT5823 and H89 on cyclic-nucleotide-mediated phosphorylation of vasodilator-stimulated phosphoprotein (VASP) in intact human platelets and rat mesangial cells. These two cell types both express high levels of cGK. KT5823 inhibited purified cGK. However, with both intact human platelets and rat mesangial cells, KT5823 failed to inhibit cGK-mediated serine 157 and serine 239 phosphorylation of VASP induced by nitric oxide, atrial natriuretic peptide, or the membrane-permeant cGMP analog, 8-pCPT-cGMP. KT5823 enhanced 8-pCPT-cGMP-stimulated VASP phosphorylation in platelets and did not inhibit forskolin-stimulated VASP phosphorylation in either platelets or mesangial cells. In contrast H89, an inhibitor of both PKA and cGK, clearly inhibited 8-pCPT-cGMP and forskolin-stimulated VASP phosphorylation in the two cell types. The data indicate that KT5823 inhibits purified cGK but does not affect a cGK-mediated response in the two different cell types expressing cGK I. These observations indicate that data that interpret the effects of KT5823 in intact cells as the major or only criteria supporting the involvement of cGK clearly need to be reconsidered.

1 August 2003 in Journal of Biological Chemistry
Verified
Journal Article
Open access
Stepan GambaryanStepan Gambaryan
Stepan Gambaryan
EBElke Butt
Elke Butt
KMKatrin Marcus
Katrin Marcus
MGMargarita Glazova
Margarita Glazova
APAlois Palmetshofer
Alois Palmetshofer
ASAlbert Smolenski
Albert Smolenski
The renin-angiotensin-aldosterone system plays a pivotal role in the regulation of salt and water homeostasis. Here, we demonstrate the expression and functional role of cGMP-dependent protein kinases (PKGs) in rat adrenal cortex. Expression of PKG II is restricted to adrenal zona glomerulosa (ZG) cells, whereas PKG I is localized to the adrenal capsule and blood vessels. Activation of the aldosterone system by a low sodium diet up-regulated the expression of PKG II, however, it did not change PKG I expression in adrenal cortex. Both, activation of PKG II in isolated ZG cell and adenoviral gene transfer of wild type PKG II into ZG cells enhanced aldosterone production. In contrast, inhibition of PKG II as well as infection with a PKG II catalytically inactive mutant had an inhibitory effect on aldosterone production. Steroidogenic acute regulatory (StAR) protein that regulates the rate-limiting step in steroidogenesis is a new substrate for PKG II and can be phosphorylated by PKG II in vitro at serine 55/56 and serine 99. Stimulation of aldosterone production by PKG II in contrast to stimulation by PKA did not activate StAR gene expression in ZG cells. The results presented indicate that PKG II activity in ZG cells is important for maintaining basal aldosterone production.

14 November 2014 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
MGMargarita Glazova
Margarita Glazova
LNLiubov S. Nikitina
Liubov S. Nikitina
KHKirill A. Hudik
Kirill A. Hudik
OKOlga D. Kirillova
Olga D. Kirillova
NDNadezhda A. Dorofeeva
Nadezhda A. Dorofeeva
ECElena Chernigovskaya
Elena Chernigovskaya

23 November 2001 in Histochemistry and Cell Biology
Verified
Journal Article
Closed access
PDF file
Stepan GambaryanStepan Gambaryan
Stepan Gambaryan
WHWolfgang Hauser
Wolfgang Hauser
AKAnna Kobsar
Anna Kobsar
MGMargarita Glazova
Margarita Glazova
UWUlrich Walter
Ulrich Walter

1 January 2006 in Molecular Medicine
Verified
Journal Article
Open access
WHWesley A. Hendricks
Wesley A. Hendricks
EPElena S. Pak
Elena S. Pak
JOJ. Paul Owensby
J. Paul Owensby
KMKristie J. Menta
Kristie J. Menta
MGMargarita Glazova
Margarita Glazova
AMAlexander K. Murashov
Alexander K. Murashov
Embryonic stem (ES) cells have been investigated in repair of the CNS following neuronal injury and disease; however, the efficacy of these cells in treatment of postinjury pain is far from clear. In this study, we evaluated the therapeutic potential of predifferentiated mouse ES cells to restore sensory deficits following spinal cord injury (SCI) in mice. The pain model used unilateral intraspinal injection of quisqualic acid (QUIS) into the dorsal horn between vertebral levels T13 and L1. Seven days later, 60,000 predifferentiated ES cells or media were transplanted into the site of the lesion. Histological analysis at 7, 14, and 60 days post-transplantation revealed that animals receiving ES cell transplants suffered significantly less tissue damage than animals receiving media alone. Transplanted cells provided immediate effects on both spontaneous and evoked pain behaviors. Treatment with ES cells resulted in 0% (n = 28) excessive grooming behavior versus 60% (18 of 30) in media-treated animals. In the acetone test (to assess thermal allodynia), mice recovered to preinjury levels by 12 days after ES cell transplant, whereas control animals injected with media after SCI did not show any improvement up to 60 days. Similarly, the von Frey test (to assess mechanical allodynia) and the formalin test (to assess nociceptive hyperalgesia) showed that transplantation of predifferentiated ES cells significantly reduced these pain behaviors following injury. Here we show that predifferentiated ES cells act in a neuroprotective manner and provide antinociceptive and therapeutic effects following excitotoxic SCI.